| Genomic hallmarks and structural variation in metastatic prostate cancer DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ... Cell 174 (3), 758-769. e9, 2018 | 639 | 2018 |
| Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer F Crea, A Watahiki, L Quagliata, H Xue, L Pikor, A Parolia, Y Wang, D Lin, ... Oncotarget 5 (3), 764, 2014 | 236 | 2014 |
| Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer A Parolia, M Cieslik, SC Chu, L Xiao, T Ouchi, Y Zhang, X Wang, P Vats, ... Nature 571 (7765), 413-418, 2019 | 227 | 2019 |
| Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2 Y Qiao, XM Wang, R Mannan, S Pitchiaya, Y Zhang, JW Wotring, L Xiao, ... Proceedings of the National Academy of Sciences 118 (1), e2021450118, 2021 | 176 | 2021 |
| Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas J Bayliss, P Mukherjee, C Lu, SU Jain, C Chung, D Martinez, B Sabari, ... Science translational medicine 8 (366), 366ra161-366ra161, 2016 | 174 | 2016 |
| Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer L Xiao, A Parolia, Y Qiao, P Bawa, S Eyunni, R Mannan, SE Carson, ... Nature 601 (7893), 434-439, 2022 | 129 | 2022 |
| The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer F Crea, E Venalainen, X Ci, H Cheng, L Pikor, A Parolia, H Xue, ... Epigenomics 8 (5), 721-731, 2016 | 116 | 2016 |
| Non-invasive metabolic imaging of brain tumours in the era of precision medicine MM Kim, A Parolia, MP Dunphy, S Venneti Nature reviews Clinical oncology 13 (12), 725-739, 2016 | 111 | 2016 |
| The non-coding transcriptome as a dynamic regulator of cancer metastasis F Crea, PL Clermont, A Parolia, Y Wang, CD Helgason Cancer and metastasis reviews 33, 1-16, 2014 | 103 | 2014 |
| Multivalent proteins rapidly and reversibly phase-separate upon osmotic cell volume change AP Jalihal, S Pitchiaya, L Xiao, P Bawa, X Jiang, K Bedi, A Parolia, ... Molecular cell 79 (6), 978-990. e5, 2020 | 97 | 2020 |
| Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role PL Clermont, L Sun, F Crea, KL Thu, A Zhang, A Parolia, WL Lam, ... British journal of cancer 111 (8), 1663-1672, 2014 | 94 | 2014 |
| The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo A Parolia, F Crea, H Xue, Y Wang, F Mo, VR Ramnarine, HH Liu, D Lin, ... Molecular cancer 14, 1-7, 2015 | 90 | 2015 |
| Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer PL Clermont, F Crea, YT Chiang, D Lin, A Zhang, JZL Wang, A Parolia, ... Clinical epigenetics 8, 1-14, 2016 | 83 | 2016 |
| Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression F Crea, L Quagliata, A Michael, HH Liu, P Frumento, AA Azad, H Xue, ... Molecular oncology 10 (5), 693-703, 2016 | 58 | 2016 |
| miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer N Nabavi, NRN Saidy, E Venalainen, A Haegert, A Parolia, H Xue, ... Scientific reports 7 (1), 4079, 2017 | 52 | 2017 |
| Epigenetic reprogramming with antisense oligonucleotides enhances the effectiveness of androgen receptor inhibition in castration-resistant prostate cancer L Xiao, JC Tien, J Vo, M Tan, A Parolia, Y Zhang, L Wang, Y Qiao, ... Cancer research 78 (20), 5731-5740, 2018 | 47 | 2018 |
| The long noncoding RNA HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program A Parolia, E Venalainen, H Xue, R Mather, D Lin, R Wu, P Pucci, ... Molecular oncology 13 (5), 1121-1136, 2019 | 30 | 2019 |
| The evolutionarily conserved long non‐coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and … RL Mather, A Parolia, SE Carson, E Venalainen, D Roig‐Carles, M Jaber, ... Molecular oncology 15 (7), 1921-1941, 2021 | 23 | 2021 |
| DNA methylation at enhancer regions: Novel avenues for epigenetic biomarker development PL Clermont, A Parolia, HH Liu, CD Helgason Front Biosci (Landmark Ed) 21, 430-446, 2016 | 22 | 2016 |
| Competing for enhancers: PVT1 fine-tunes MYC expression A Parolia, M Cieślik, AM Chinnaiyan Cell Research 28 (8), 785, 2018 | 17 | 2018 |
Crea FrancescoProfessor of Cancer Pharmacology, The Open University確認したメール アドレス: open.ac.uk
